The initiative to have the Massachusetts Medicaid system include Zyban in their formulary for smoking cessation as a drug intervention therapy is a collaborative with the Worcester Healthcare Outreach and Worcester Polytechnic Institute. Research through relevant literature and contact with professionals in the medical discipline showed data that permitted a proposal for a study to directly link Zyban to cost savings. Access to drug cessation therapies can provide general improvement in health as well as save costs for the state.
Worcester Polytechnic Institute
Interactive Qualifying Project
Access to this report is limited to members of the WPI community. Please contact a project advisor or their department to request access
Restricted-WPI community only
Biology and Biotechnology